Ginkgo Bioworks Holdings Inc (DNA): Can not short it but I can trade options...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	659
Posts	24171
Boards Moderated	4
Alias Born	12/03/2007

buyittradeit

Re: Porterhouse10 post# 310

Friday, 10/21/2022 11:45:14 AM

Friday, October 21, 2022 11:45:14 AM

Can not short it but I can trade options here thanks for the heads up

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent DNA News

Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/17/2024 08:50:34 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/17/2024 02:24:38 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/16/2024 02:31:26 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/15/2024 05:24:56 PM
Ginkgo Bioworks to Participate in Two Conferences in May • PR Newswire (US) • 05/15/2024 11:01:00 AM
Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan • PR Newswire (US) • 05/14/2024 10:00:00 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2024 02:48:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:14:34 PM
Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSE • PR Newswire (US) • 05/13/2024 08:05:00 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2024 02:50:14 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/10/2024 02:10:28 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/09/2024 09:16:40 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:11:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:02:50 PM
Ginkgo Bioworks Reports First Quarter 2024 Financial Results • PR Newswire (US) • 05/09/2024 08:01:00 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/09/2024 02:13:26 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/08/2024 02:43:03 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2024 03:40:10 PM
GreenLab Partners with Ginkgo Bioworks to Scale Up Production of Brazzein, a Novel Sweetener • PR Newswire (US) • 05/07/2024 11:01:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 08:55:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 08:53:23 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2024 02:43:30 PM
Ginkgo Bioworks Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting • PR Newswire (US) • 05/06/2024 11:01:00 AM

More DNA News

InvestorsHub NewsWire

FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover